Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurocognitive Effects of Opiate Agonist Treatment (NEO)
NCT01733693Phase 4Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jan 2013
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in opioid use disorder (OUD), sponsored by Albert Einstein College of Medicine. Started Jan 2013; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01733693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01733693.